Recent Quotes
My Watchlist
Indicators
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

301.86 +6.75 (+2.29%)
Streaming Delayed Price Updated: 10:15 AM EDT, Aug 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2
...
16 17 18 19 20 21 22 23 Next >
News headline image
Charles River Acquires Viral Vector Player For $350M ↗
Contract researcher Charles River Laboratories International Inc (NYSE: CRL) will dole out $292.5 million for gene therapy CDMO Vigene Biosciences with the... 
Via Benzinga
News headline image
Charles River Laboratories to Acquire Vigene Biosciences to Enhance Gene Therapy Capabilities
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Labs Joins Elite List Of Stocks With 95-Plus Composite Rating ↗
Charles River Labs' Accumulation/Distribution Rating of A, on an A+ to E scale, shows heavy buying by institutional investors over the last 13 weeks. 
Via Investor's Business Daily
News headline image
Charles River Laboratories International Inc (CRL) Q1 2021 Earnings Call Transcript ↗
CRL earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Stocks That Hit 52-Week Highs On Thursday ↗
Thursday morning saw 166 companies set new 52-week highs. Interesting Highlights: The largest company by market cap to hit a new 52-week high was Microsoft (NASDAQ:... 
Via Benzinga
News headline image
Charles River: Q1 Earnings Insights ↗
Shares of Charles River (NYSE:CRL) decreased 0.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 37.50% year over... 
Via Benzinga
News headline image
Charles River Laboratories Announces First-Quarter 2021 Results
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Three Medical Stocks To Watch, Including One With A Potential Breakout ↗
Two have recent breakouts under their belts while a third is eyeing a fresh buy point. 
Via Investor's Business Daily
News headline image
Medpace Holdings Stock At The Top Of Buy Range With Earnings On Deck ↗
Medpace is in a potential buy range with its next earnings report scheduled for Apr. 26. The medical stock is about 3% above a 177.22 buy point from a second-stage... Read More 
Via Investor's Business Daily
News headline image
Charles River Laboratories Schedules First-Quarter 2021 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
< Previous 1 2
...
16 17 18 19 20 21 22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.